Valisure President David Light spoke at DOC 2025: The Science of Longevity — Clinical Breakthroughs, AI, and Women’s Health, held at The Estate Yountville in Napa Valley, California. The immersive conference brought together leading researchers, clinicians, and innovators to explore the intersections of longevity science, artificial intelligence, and women’s health through a series of debates, fireside chats, and interactive sessions.

David led a breakout discussion titled “Low-Quality Generics Cause Harm, Cost Billions, and Diminish Optimal Longevity. But There is a Solution!” in the Barrel Room, where he highlighted the significant health and economic consequences of substandard generic drugs. He also emphasized Valisure’s mission to bring transparency and independent testing to the pharmaceutical supply chain as a foundation for improved long-term health outcomes.

DOC 2025 featured thought-provoking sessions, including “The Great Debate: When, if ever, will AI replace doctors?”, and presented actionable insights from academic and industry leaders focused on empowering individuals to measure, monitor, and improve their own health.

Valisure is proud to contribute to this global conversation on how innovation, data, and drug quality intersect to advance longevity and redefine the future of medicine.

Valisure President David Light spoke at DOC 2025: The Science of Longevity — Clinical Breakthroughs, AI, and Women’s Health, held at The Estate Yountville in Napa Valley, California. The immersive conference brought together leading researchers, clinicians, and innovators to explore the intersections of longevity science, artificial intelligence, and women’s health through a series of debates, fireside chats, and interactive sessions.

David led a breakout discussion titled “Low-Quality Generics Cause Harm, Cost Billions, and Diminish Optimal Longevity. But There is a Solution!” in the Barrel Room, where he highlighted the significant health and economic consequences of substandard generic drugs. He also emphasized Valisure’s mission to bring transparency and independent testing to the pharmaceutical supply chain as a foundation for improved long-term health outcomes.

DOC 2025 featured thought-provoking sessions, including “The Great Debate: When, if ever, will AI replace doctors?”, and presented actionable insights from academic and industry leaders focused on empowering individuals to measure, monitor, and improve their own health.

Valisure is proud to contribute to this global conversation on how innovation, data, and drug quality intersect to advance longevity and redefine the future of medicine.